Hepatitis B Core IgM antibody (anti-HBcIgM) among hepatitis B Surface antigen (HBsAg) negative blood donors in Nigeria

Virology Journal

Volumn 8, Issue , 2011, Pages

  Japhet, Margaret ^a,b   Adesina, Olufisayo ^a,b   Donbraye, Emmanuel ^a,b   Adewumi, Moses ^b  

^a OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

^b UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Blood donors; ELISA; Hepatitis B; Serological markers; Transfusion

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN M; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIGEN;

ADULT; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; DEMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MALE; NIGERIA; PREVALENCE; SCREENING; SEROLOGY; TRANSFUSION; ADOLESCENT; BLOOD; HEPATITIS B VIRUS; IMMUNOLOGY; MIDDLE AGED;

HEPATITIS B VIRUS;

ADOLESCENT; ADULT; BLOOD DONORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; NIGERIA; YOUNG ADULT;

EID: 80755125787     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-513     Document Type: Article

References (27)

1. Seroprevalence of Hepatitis B surface antigen among prospective Blood donor in an Urban Area of Benue state. Alao OO, Okwori OO, Egwu C, Audu F, The internet J of Hematology 2009 5 2
2. Hepatits B virus epidemiology, disease burden, treatment and current and emerging prevention and control measures. Lavanchy D, J viral Hepatol 2004 11 2 97 107 10.1046/j.1365-2893.2003.00487.x (Pubitemid 38365759)
3. What is the reason for poor outcome of Antepartum immunopoplylaxis of Heptatis B Immunoglobulin in prevention of vertical Hepatitis B Transmission? Alavian Seyed-Moayed, Behnava Bita, Heptatitis monthly 2007 7 3 163 165
4. Anti-HBC screening of blood donors: a comparison of nine anti-HBc test. Schmidt M, Nubling CM, Scheiblanres H, Chudy M, Walch LA, Seifried E, Roth WK, Hourfar MK, Vox sang 2006 91 237 243 10.1111/j.1423-0410.2006.00818.x 16958836 (Pubitemid 44337281)
5. Chronic hepatitis B. Lok AS, N Engl J Med 2002 346 1682 1683 10.1056/NEJM200205303462202 12037146
6. Hepatitis B. Hicks Rob, 2009 http://www.bbc.co.uk/health/physical-health/ conditions/hepatitisb1.shtml
7. Heptatis B virus Biology. Christopher S, William SM, Microbiology and Molecular Biology Reviews 2000 64 1 51 68 10.1128/MMBR.64.1.51-68.2000 10704474
8. Acute viral hepatitis. Cohen Sidney, The Merck manual online Medical Library 2007 2006-2008
9. Hepatitis B: diagnosis, Prevention and Treatment. Gitlin Norman, Clinical Chemistry 1997 43:8 B 1500 1506
10. The role of anti-HBc IgM in Screening of Blood Donors. Kumar H, Gupta PK, Jaiprakash Brig M, MJAFI 2007 63 350 352 (Pubitemid 350111233)
11. Evidence of occult Hepatitis B Virus infection among Omani Blood Donors: A preliminary study. Geraldine K, Adel A, Intesar A, Jameel N, Said HA, Medical Principle and Practice 15 368 372
12. High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis c virus related chronic liver disease in Japan. Marusawa H, Osaki Y, Kimura T, Ito K, Yamashita Y, Eguchi T, Kudo M, Yamamoto Y, Kojima H, Seno H, Moriyasu F, Chiba T, Gut 1999 45 2 284 288 10.1136/gut.45.2.284 10403743 (Pubitemid 29333780)
13. cpositive blood donors: Necessitates substitutionof screening by HBV NAT. Panhotra BR, Bahrani A, Joshi CS, Ul Hassan Zahoor, J Infect 2005 51 3 263 16125778 (Pubitemid 41554840)
14. Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen. Hennig H, Puchta I, Luhm J, Luhm J, Schlenke P, Goerg S, Kirchner H, Blood 2002 100 2637 41 10.1182/blood-2002-03- 0798 12239179
15. Is infective blood donation missed out without screening for antibody to hepatitis B core antigen and/or hepatitis B virus DNA. Muhlbacher A, Zdunek D, Melchior W, Michl U, Vox Sang 2001 81 139 10.1046/j.1423-0410.2001.00086.x 11555477 (Pubitemid 35369993)
16. Significance of HBV DNA in HBsAg negative individuals: a critical commentary. Vyas GN, Transfusion associated hepatitis. Diagnosis, treatment and prevention New Delhi: CBS Publishers & Distributors, Sarin SK, Hess G, eds, 1998 49 56
17. Ctitre and PCR amplified HBV DNA. Chaudhuri V, Nanu A, Panda SK, Chand P, Transfusion 2006 43 10 1442 1448 (Pubitemid 37322506)
18. Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. Hoofnagle JH, Seef LB, Bales ZB, Zimmerman HJ, N Engl J Med 1978 298 1379 83 10.1056/NEJM197806222982502 652005 (Pubitemid 8358627)
19. Absence of hepatitis B DNA detected by polymerase chain reaction in blood donors who are hepatitis B surface antigen negative and antibody to hepatitis B core antigen positive from a United States population with a low prevalence of hepatitis B serologic markers. Douglas DD, Taswell HF, Rakela J, Rabe D, Transfusion 1993 33 212 6 10.1046/j.1537-2995.1993.33393174446.x 8438221 (Pubitemid 23073643)
20. Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients. An analysis of Transfusion Transmitted Virus Study. Stevens CE, Aach RD, Hollinger FB, Mosley JW, Szmuness W, Kahn R, Werch J, Edwards V, Ann Intern Med 1984 101 733 8 6437308 (Pubitemid 15187359)
21. Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients. Mosley JW, Stevens CE, Aach RD, Hollinger FB, Mimms LT, Solomon LR, Barbosa LH, Nemo GJ, Transfusion 1995 35 5 12 10.1046/j.1537-2995.1995.35195090661.x 7998069
22. Serological pattern 'anti-HBc alone': Report on a workshop. Grob P, Jilg W, Bornhak H, Gerken G, Gerlich W, Gunther S, Hess G, Hudig H, Kitchen A, Margolis H, Michel G, Trepo C, Will H, Zanetti A, Mushahwar I, J Med Virol 2000 62 450 5 10.1002/1096-9071(200012)62:4<450::AID-JMV9>3.0.CO;2-Y 11074473
23. Occult hepatitis B virus infection: implications in transfusion. Allain JP, Vox Sang 2004 86 83 91 10.1111/j.0042-9007.2004.00406.x 15023176 (Pubitemid 38436885)
24. Hepatitis B virus markers, hepatitis D virus antigen and hepatitis C virus antibodies in Nigerian patients with chronic liver disease. Ojo OS, Thursz M, Thomas HC, Ndububa DA, Adeodu oo, Rotimi O, Lawal AA, Durosimi MA, Akonai AK, Fatusi AO, Goldn RD, East Afr Med J 1995 72 11 719 21 8904063
25. Viral antibodies and the infectivity of serum in hepatitis B. Neirmeijer P, Gips CH, N Engl J Med 1978 299 958 692610
26. Detection of hepatitis B DNA in serum and relation with the IgM class anti-HBc titres in hepatitis B infection. van Ditzhuijsen TJ, Selten GC, van Loon AM, Wolters G, Matthyssen L, Yap SH, J Med Virol 1985 15 49 56 10.1002/jmv.1890150107 3968544 (Pubitemid 15184361)
27. Preventing Post-Transfusion Hepatitis by screening blood donors for IgM Antibody to Hepatitis B core antigen. Sawke Nilima G, Sawke GK, J Glob Infect Dis 2010 2 3 246 247 10.4103/0974-777X.68526 20927286